UQ Researchers Develop New Visual Tests to Detect Early Parkinson’s Dementia
- Australian researchers have engineered visual diagnostic tests designed to uncover the earliest indicators of dementia linked to Parkinson's disease, as detailed in an Oct.
- This novel clinical approach zeroes in on Lewy body disease, a classification covering both Parkinson's disease and dementia with Lewy bodies.
- Impaired visual processing operates as an early hallmark of the condition, frequently surfacing prior to the manifestation of other distinct symptoms.
Early Detection Tests Target Parkinson’s Dementia
Australian researchers have engineered visual diagnostic tests designed to uncover the earliest indicators of dementia linked to Parkinson’s disease, as detailed in an Oct. 14, 2026 University of Queensland statement covered by english.news.cn.
This novel clinical approach zeroes in on Lewy body disease, a classification covering both Parkinson’s disease and dementia with Lewy bodies. Ranking as the second most common form of degenerative dementia, the condition takes root when abnormal clumps of a protein termed alpha-synuclein—known as Lewy bodies—gather within the brain’s nerve cells, ultimately disrupting regular neurological function.
Mapping Brain Pathways and Visual Processing
Impaired visual processing operates as an early hallmark of the condition, frequently surfacing prior to the manifestation of other distinct symptoms. Professor Peter Nestor, a neurologist at the University of Queensland’s Queensland Brain Institute who spearheaded the development of the tests, noted this temporal pattern.
The scientific team concentrated their efforts on two distinct visual pathways. The first pathway manages object recognition, while the second oversees spatial localization. Published in the Journal of Neurology, the study assessed visual processing across the complete spectrum of Lewy body disease.
Evaluating Diverse Neurodegenerative Conditions
The investigative framework encompassed participants diagnosed with Parkinson’s disease who exhibited no prior cognitive symptoms, alongside individuals living with Alzheimer’s disease.
Data from the study showed that visual deficits proved more pronounced in patients with Lewy body disease compared to those with Alzheimer’s disease. Additionally, the results indicated that these two neurodegenerative conditions impact visual processing pathways via entirely distinct mechanisms. The research additionally established a direct correlation between visual processing impairments and visual hallucinations, a frequent clinical manifestation of Lewy body disease.
Uncovering Hidden Deficits in Patients
According to Nestor, the freshly devised assessments successfully isolate the earliest emergence of dementia tied to Lewy body disease.
This diagnostic reach even extends to uncovering visual processing deficits among specific Parkinson’s disease patients who previously remained entirely unaware of the impairments.